This inventor holds 5 USPTO granted patents and 5 published patent applications, plus 3 CIPO patents and 4 EPO patents. Top assignee: Altor Bioscience Corporation. Active years: 2003-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2016
Title: Innovator Spotlight: Kimberlyn F. Card
Introduction: Kimberlyn F. Card, an accomplished inventor based in Pembroke Pines, Florida, has made significant contributions to the field of biotechnology. With a total of five patents to her name, she is known for developing innovative solutions that enhance the detection and treatment of diseases, particularly cancer.
Latest Patents: Among her latest patents, Kimberlyn has developed soluble TCR (T-cell receptor) molecules and methods of use. These inventions provide compositions and methods for detecting cells or tissues that comprise a peptide antigen presented in the context of an MHC (Major Histocompatibility Complex) or HLA (Human Leukocyte Antigen) complex. The applications of her groundbreaking work are vast, offering highly sensitive methods for early detection of cancer cells, which can ultimately lead to more effective treatments and improved patient outcomes.
Career Highlights: Kimberlyn currently works at Altor Bioscience Corporation, a leading biotechnology company known for its focus on immunotherapy and novel approaches to treating cancer. Her expertise and innovative spirit have been pivotal in advancing the company's research and development initiatives, particularly in the realm of cancer treatment.
Collaborations: Throughout her career, Kimberlyn has collaborated with several notable professionals in her field, including Hing C. Wong and Jon A. Weidanz. These partnerships have fostered an environment of innovation and creativity, leading to significant advancements in cancer detection and treatment methodologies.
Conclusion: Kimberlyn F. Card stands out as a prominent figure in the biotechnology industry. Her inventive contributions, particularly in developing soluble TCR molecules, have opened new avenues for cancer detection and treatment. Through her dedication and collaboration with peers, she continues to push the boundaries of innovation, ultimately aiming to improve the lives of countless individuals affected by cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile